Skip to content
Menu

NovoCure Raises FY2026 Sales Guidance from $710.000M-$725.000M to $736.000M-$743.000M vs $725.814M Est

Benzinga Newsdesk 3 weeks ago

NewsGuidance

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

NovoCure (NASDAQ:NVCR) raises FY2026 sales outlook from $710.000 million-$725.000 million to $736.000 million-$743.000 million vs $725.814 million estimate.

NovoCure (NASDAQ:NVCR) raises FY2026 sales outlook from $710.000 million-$725.000 million to $736.000 million-$743.000 million vs $725.814 million estimate.

Read at benzinga.com

← All stock news